| Dr Kristine E Traustason, MD | |
|
1775 Sw Umatilla Ave, Redmond, OR 97756-7197 | |
| (541) 548-7170 | |
| (541) 548-3842 |
| Full Name | Dr Kristine E Traustason |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 23 Years |
| Location | 1775 Sw Umatilla Ave, Redmond, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659396711 | NPI | - | NPPES |
| P00464413 | Other | OR | RAILROAD MEDICARE |
| 007221 | Medicaid | OR | |
| 053857011 | Other | OR | REGENCE BCBS |
| 76149 | Other | OR | CLEAR CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD27028 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orion Eye Center Llc | 1759526767 | 6 |
News Archive
UK-based biotechnology firm ILC Therapeutics has announced a research partnership with the University of St Andrews in a bid to progress a therapeutic drug which can treat COVID-19 towards clinical trials.
Lecturers at Sheffield Hallam University are trying to encourage more young people to consider a career in radiotherapy with a series of open events at hospitals aimed at tackling the increasing demand for patients receiving the treatment.
Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.
Australian researchers have found that there is a very strong possibility that youth really is wasted on the young.
Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
› Verified 9 days ago
| Entity Name | Orion Eye Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992044903 PECOS PAC ID: 1759526767 Enrollment ID: O20130322000112 |
News Archive
UK-based biotechnology firm ILC Therapeutics has announced a research partnership with the University of St Andrews in a bid to progress a therapeutic drug which can treat COVID-19 towards clinical trials.
Lecturers at Sheffield Hallam University are trying to encourage more young people to consider a career in radiotherapy with a series of open events at hospitals aimed at tackling the increasing demand for patients receiving the treatment.
Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.
Australian researchers have found that there is a very strong possibility that youth really is wasted on the young.
Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristine E Traustason, MD 1775 Sw Umatilla Ave, Redmond, OR 97756-7197 Ph: (541) 548-7170 | Dr Kristine E Traustason, MD 1775 Sw Umatilla Ave, Redmond, OR 97756-7197 Ph: (541) 548-7170 |
News Archive
UK-based biotechnology firm ILC Therapeutics has announced a research partnership with the University of St Andrews in a bid to progress a therapeutic drug which can treat COVID-19 towards clinical trials.
Lecturers at Sheffield Hallam University are trying to encourage more young people to consider a career in radiotherapy with a series of open events at hospitals aimed at tackling the increasing demand for patients receiving the treatment.
Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.
Australian researchers have found that there is a very strong possibility that youth really is wasted on the young.
Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
› Verified 9 days ago
Dr. Oli I Traustason, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1775 Sw Umatilla Ave, Redmond, OR 97756 Phone: 541-548-7170 Fax: 541-548-3842 | |
Ryan Constantine, M.D., PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1775 Sw Umatilla Ave, Redmond, OR 97756 Phone: 541-548-7170 Fax: 541-548-3842 |